Massive, nearly monodisperse, true microencapsulation of a wide variety of active ingredients within biocompatible shells can be achieved using flow focusing at moderate-high Reynolds numbers, a paradigmatic tool for highly controlled flow chemistry processes whose flexibility and physical aspects are briefly illustrated here. We show that the natural, regular capillary breakup of a laminar high-speed microjet produced by gentle mechanical means alone allows the production of true microcapsules with controlled dimensions. The process versatility is shown in a variety of examples including encapsulation of different materials as proteins and/or microorganisms in biocompatible polymers as poly-L-glutamic acid (PLGA). Microcapsules produced show nearly homogeneous size, well-centered core, and their size and structure are well predicted by simple theoretical models.
Introduction
The use of microcapsules is currently widespread from pharmaceutical and food industry to cosmetics, agriculture, and even high-energy physics (inertial confinement pellets [1] ). There are many methods and techniques to produce microparticles [2] . The characteristics of the microcapsules ultimately depend on the final goal of the encapsulated product, as they can be used to entrap all sorts of substances: solids, liquids, drugs, proteins, bacterial cells, and so forth. In any case, microencapsulation involves an active core covered by a sufficiently protective shell which often regulates the time release of the active core principle. A conceptually flexible way to produce such cover within the flow chemistry philosophy is to make the shell-making liquid to flow coaxially around the core liquid, stretching the coaxial liquid stream into a high speed, extremely thin capillary jet [3] . This jet would eventually breakup into spherical capsules by capillary instability and the effect of surface tension. Previous attempts to efficiently stretch the coaxial streams involve (1) the use of electrostatic fields [4] , which imposes severe physicochemical and technological limitations to its wide range implementation leading to very restrictive results, and (2) low Reynolds flow through axisymmetric microcapillary geometries [5] , which provides a limited yield and capsule sizes typically above 100 μm. Flow focusing at moderate-high Reynolds number provides uniquely flexible means to mass produce concentric two-phase microdroplets, which lead to generic and widely applicable microcapsules after the external liquid cover is hardened. One of the fundamental features offered by flow focusing is the use of purely hydrodynamic means (a focusing fluid stream forced through a small but not prone to clogging orifice) efficiently aimed at the controlled formation of the high-speed coaxial capillary microjet which gives rise to the stream of compound microdroplets (see Figure 1 ). Using this method, nearly monodisperse, true, and flexible microencapsulation has been achieved below 10 μm.
Here, we show that the natural, regular capillary breakup of a laminar high-speed microjet produced by gentle mechanical means alone provides an optimum paradigm for the continuous high-frequency (10 kHz to 1 MHz) production of true microcapsules below 10 μm. The biocompatible polymer poly-Lglutamic acid (PLGA) was used as shell forming agent, and different substances were encapsulated: microorganisms for food and dairy industry, biomolecules, crystals of salts controllably grown, or liquids are some illustrative examples of core materials that revelled the versatility of flow focusing.
1.1. Predicting Physical Model. The physical argument behind our model rests on the same feature allowing mass productivity of our system, i.e., that the liquid inertia is sufficiently large compared to both viscous and surface tension forces, which allows the formation of a moderate-high Reynolds number liquid jet. Under these circumstances, kinetic energy per unit fluid volume builds up almost entirely from the imposed pressure drop across the orifice [6] . For the pressure ranges used in our study , the liquid stream focused by the action of the coflowing gas forms a laminar microjet whose speed ranges from 4 to 8 m/s. In our study, the jet has a small diameter d j from some micrometers to tens of micrometers and is comprised of two immiscible liquids arranged coaxially. The resulting coaxial jet breaks up into droplets at an extremely high rate
where f is the droplet generation frequency, Q is the jet total flow rate, and k f is a constant (whose typical value is between 0.3 and 0.5, depending on the Reynolds number and the ratio of inertia to surface tension forces, or Weber number [6] ). Compatible with a flow chemistry process, that construct can be easily multiplexed and the process scaled up to meet virtually any production demand. Moreover, as long as inertia does not overcome the conforming or restoring role of surface tension when the jet breaks up, the resulting droplet size d g is related to the external jet diameter approximately as predicted by Rayleigh, i.e., d g ≅ 1.89d j , which corresponds to a breakup wavelength l ≅ 4.5d j . In this case, k f = 4/(4.5π). This happens when the Weber number We = d j ΔP/σ 2 is not larger than about 20 [6, 7] where σ 2 is the interfacial tension between the external liquid and the focusing gas. Thus, the breakup frequency f ranges from tens of kHz to about some MHz, which means that about 1 million microcapsules per second can be produced.
Owing to (a) the small diameter of the jet and (b) the similar values of the densities of both liquids, transversal viscous diffusion makes the liquid velocity profile nearly flat (homogeneous) a few jet diameters downstream after the jet is formed. Thus, the resulting external jet diameter can be calculated [6] as if the liquid had a weighted density ρ À calculated from the liquids flow rate ratio, as
which results in a theoretical external jet diameter after the orifice exit approximately given by 4 :
where Q 1 and Q 2 are the inner and outer liquids flow rates, respectively, and ΔP l is the resulting pressure drop applied on the external liquid. The internal jet diameter d j1 is thus given by:
where ΔP l is related to the pressure drop applied on the gas ΔP by:
Substituting the definition of the Weber number We = d j ΔP/ σ 2 = d j /d o (see ref. [6] ) in eq. (4) and using eq. (2), one obtains a nondimensional expression for We as:
provided that the jet is formed (We >~6), where
. Equation (5) gives the theoretical asymptotic jet diameter of a liquid with surface tension σ 2 when viscous forces are negligible, i.e., when the Reynolds number Re ¼ ρ À Ud j =μ 2 is large enough and both inner and outer liquid viscosities μ 1 and μ 2 are comparable. The neglect of viscous forces involves relative errors of the order of Re −1 in the calculation of jet diameter. For a deeper insight on the role of viscosity on the jet size and shape, we refer the reader to a recent paper [8] .
1.1.1. Useful Parametrical Limits of Jetting. Our parametrical working limits are given by (a) the transition from an axisymmetric to an asymmetric jet breakup (We ≤ 20) [7] , and by (b) the transition from jetting to dripping [9, 10] . The latter was theoretically considered by Leib and Goldstein (1986) , who gave the value of a critical jet Weber number as a function of the Reynolds number Re. Their critical Weber number We LG * is related to ours, We*, by the expression We
In their study, Leib and Goldstein obtained a critical Weber number for large Reynolds which corresponds to our We* = 5.11. Thus, it is sufficient for our purposes to define a useful working range:
In this range, a jet is convectively unstable and breaks up axisymmetrically following Rayleigh's prediction (when liquid viscosity is small) approximately, yielding small and nearly monodisperse droplets. In view of the relatively large We values given by eq. (6), the Taylor series expansion of the solution to eq. (5) can be expressed in terms of the nondimensional total liquid flow rate θ ¼
as: Thus, taking the first two terms of the series:
Thus, a useful range for the total flow rate Q 1 +Q 2 can be finally expressed as:
Within this range, the jet diameter is given by:
with errors of the order of We −2 and Re −1 . Assuming that the jet breaks up following Rayleigh's prediction governed by the outer surface tension σ 2 (typically much larger than the surface tension between the two coaxial liquids), the resulting compound droplet would have an external diameter d g = 1.89d j , with an internal core diameter d 1 given by:
where d 1j is the inner jet diameter.
Capsule Hardening and Solvent
Remains. The resulting compound droplets can form true capsules after a physical process where either the shell alone, or both shell and core, undergo hardening via evaporation, freezing, gelation, etc. The case of evaporation is indeed the more complex since it entails coupled mass and thermal energy exchange with the environment. In most cases, the use of solvents is a necessary but sometimes undesired ingredient of the process, whose final presence in the capsule should be quantified. Thus, from the experimentally measured capsule external and internal diameters (d e and d i , respectively) and the initial liquid droplet size given by the theoretical predictions, we can calculate the solvent remains in both the shell and core. Solvent remains per initial unit volume of solvent for both the shell and the core can be calculated using the expressions
as functions of the external and internal capsule diameters, d e and d i , respectively. v shell and v core are the volume concentrations of solute in the liquid solutions forming shell and core, respectively. The physical relationship linking the solvent remains with the operating parameters, and initial droplet size/structure is a nontrivial matter that we aim to illustrate in the following, among other issues.
Results and Discussion
Our previous studies in FF encapsulation have demonstrated the versatility of this technology. We have successfully encapsulated: (1) small molecules as lidocaine, tobramycin, or gemtabicine with proved anticancer activity; (2) biomolecules as insulin or green fluorescent protein (GFP); and (3) encoded fluorescent magnetic polystyrene microparticles for diagnostic purposes [11] . Now, we have employed a new flow focusing configuration to produce true microcapsules with a core-shell defined structure.
First of all, we have studied the correlation between theoretical and experimental data and the ability of this configuration to control core-shell ratio. We have made a detailed study where different gas pressures and inner and outer liquid flow rates have been explored (see Supporting Information, Tables 1  and 2 for details). In this case, commercial ink was encapsulated into PLGA matrix. The liquid used for the shell is a 3% w/v solution of PLGA in ethyl acetate (volume of PLGA per unit solution volume v shell = 0.0224). Its density and viscosity are 910 kg·m −3 and 0.0012 Pa·s, respectively. Besides, the ink used in our experiments (with a volume of dry residue per unit volume v core = 0.007) has a density and viscosity of 1005 kg·m −3 and 0.00105 Pa·s, respectively. The PLGA solution has an interfacial tension with the ink equal to 5.9 mN/m, while its surface tension in air is 23.4 mN/m. We produced the coaxial microjets in steady regime, showing a robust behavior during several hours. We have used our theoretical model to calculate the initial jet diameter and its corresponding associated errors, proportional to the experimentally calculated We −2 (which ranged from 0.0072 to 0.018) and Re −1 (which ranged from 0.0175 to 0.025). The jet should theoretically breakup axisymmetrically since (1) the Weber number ranges from 7.47 to 11.78 in all our experiments, within the range given by eq. (6), and (2) the minimum Reynolds number is 37, which warrantees that viscous forces can be neglected in most of the breakup process. We have measured the resulting droplet size in flight using a high speed camera 4Quick from Stanford Computer Optics (Figure 1a) . We have found a maximum error of about 10% between the experimental measurements and the theoretical predictions given by eqs. (2), (3), and (10), which could be attributed to several experimental uncertainties in addition to the effect of the Weber and Reynolds numbers (Figure 1a) . The droplets formed are then introduced in a small lab spray dryer (see Experimental section), where they undergo an almost complete evaporation. The drying process is gentle enough to preserve the spherical droplet configuration until it reaches its cured (dried) state. We have observed that microcapsule size exhibits an evident homogeneity and a precise control of the shell thickness just using proper flow rates (Figures 1b and c) . From an obvious causality argument applied to the parent droplet, such size accords to predictions within the parametrical ranges of interest here (Figure 1a) .
Since the shell material (i.e., the PLGA solution) is unable to undergo traction stresses during shrinkage that could justify the production of high pressures in the core, water diffusion through the concentrating PLGA-ethyl acetate solution should be mainly driven by strong water concentration gradients in the shell only. Since no trace of ink pigments is observed in the shell, its porosity should be sufficiently small to allow the selective diffusion of water molecules only. Figure 2a shows Figure 4 . Confocal laser scanning microscopy (CLSM) images of: (a) GFP-PLGA microcapsules (P = 175 mbar; Q i (0.15 mg/mL) = 3 mL/h; Q e = 0.5 mL/min); (b) E. coli-PLGA microcapsules (P = 175 mbar; Q i = 4 mL/h; Q e = 0.75 mL/min (105 bac/mL)); (c) S. cerevisiae-PLGA microcapsules P = 125 mbar; Q i = 3 mL/h; Q e = 1 mL/min (10 yeast/mL) the solvent remains per initial unit of solvent volume at both the shell and the core, R shell and R core , respectively. Interestingly, we find a clear correlation between the solvent remains and the capsule diameters d e and d i . Consistently, vapor pressures of both ethyl acetate and water at 56°C (45.5 kPa and 17 kPa, respectively) are inversely proportional to the amount of solvent remains measured, except when an almost complete drying occurs. Consistently as well, solvent remains increase with the corresponding shell or core volumes. Assuming linear relationships and that the core shrinks in accord to the water volume loss, we find complete drying for our given conditions (56°C and 101.2 kPa atmospheric pressure), for a core and shell diameters d i * = 2.1 and d e * = 7.0 μm, for the residence time of the particles in the custom-made spray dryer used in our experiments (see Figure 2a) . The existence of a single complete drying diameter for both shell and core is consistent with the use of a single residence time in the dryer that we have adjusted for the specific nature of our process. One may represent the solvent remains as a function of the resulting core and shell diameters made dimensionless with d i * and d e * (Figure 2b ). This representation unveils a surprising result: all data seem to collapse into a single trend of a very simple form R = A(d/d*) in spite of the different nature of the solvents used for shell and core. This result points to the existence of a single controlling evaporation mechanism in the process, and that cannot be other than the shell evaporation. Obviously, the resulting PLGA shell after evaporation should have a certain porosity which allows the diffusion of water through it. Thus, while the shell is undergoing evaporation, its solvent may act as a tampon for the core solvent, which progressively fills the room left in the shell matrix as its solvent evaporates. Given the negligible solvent volume present in the core compared to that in the shell, its effect on the shell volume is hardly noticeable and gets buried in the experimental errors.
The discovered controlling role of the shell evaporation becomes prominent when the shrinkage of the shell is not sufficient to follow the core shrink, and an almost spherical cavity is formed in its core replacing the initial ink vesicle, whose water content eventually finds its way out the capsule through the porous PLGA shell. In this case, a dry remain in the cavity not completely filling its volume can be observed (Figure 3) .
In order to investigate this interesting occurrence and its possible impact on sensitive materials we have encapsulated: (1) green fluorescent protein (GFP), as a biomolecule model; (2) recombinant bacteria (Escherichia coli, E. coli) and yeast (Saccharomyces cerevisiae) expressing GFP as a biological model systems. The stability and/or viability of these actives were tested by confocal laser scanning microscopy (CLSM) for rapid detection of changes in bacterial growth as well as fluorescence characteristics inside the capsule (Figure 4) .
As it can be seen in Figure 4 , reduced microparticles (5-8 μm in diameter) kept capsule integrity after drying process and were sufficiently robust to entrap labile proteins and microorganisms with different shapes and sizes.
GFP-E. coli viability after spray-drying process was tested. Cells suspended in phosphate buffer saline (PBS) were sprayed using ethyl acetate (EA) as shell or a PLGA solution in EA. Free cell or encapsulated E. coli were directly collected on culture medium plates. Cells were grown aerobically at 37°C for short periods of time ( Figure 5) .
The bactericidal activity of PLGA capsules on GFP-expressing E. coli cells was also observed under a fluorescence microscope. The excitation wavelength was 445-495 nm, and the observation filter had a long-pass filter wavelength above 515 nm.
Free and encapsulated GFP-E. coli were grown in culture media at 37°C. In both cases, bacteria were able to grow in culture media. As it was expected, free E. coli growth was faster than for encapsulated bacteria which must break the capsules and form colonies in the plate media.
These small microcapsules produced by flow focusing have shown their capability to reach difficult targets so far, such as those related with protein delivery to the intravitreous space of rats [12] . Moreover, they can play an important role in the continuous production of antibiotics and other therapeutic molecules, the development of synthetic organs, bone regeneration, or the treatment of neurodegenerative diseases [13] [14] [15] .
Additionally, core-shell microcapsules provide perfect cages for controlled microcrystal growth. To illustrate that, we have Figure 5 . Viability of free and encapsulated GFP recombinant E. coli after spray-drying process using a concentric flow focusing nozzle: (a) PBS as control; (b) and (c) growth of sprayed free E. coli after few seconds and minutes; (d) and (e) growth of sprayed encapsulated E. coli after few seconds and minutes; (f) fluorescence of encapsulated E. coli also encapsulated aqueous ClNa solutions in the same PLGA shell. In Figure 6 , microcrystals formed from the salt solution with a well-preserved crystallization structure, enclosed in a PLGA microcage, are shown.
This strategy illustrates a novel conceptual one-way method to produce controlled microencapsulated microcrystals of salt or any other substance, including proteins. Instead of using an internal nucleation seed to trigger the crystal growth, we isolate a well-defined salt solution volume and provoke its controlled concentration inside a hardening shell which provides the eventual encapsulation of the microcrystal.
This method can be useful to prevent the presence of drug crystal on microparticles surfaces avoiding burst effects and changes on powder flow properties (which can lead to inconsistent filling during tableting, for example). Moreover, it is possible to control the crystalline or amorphous form of a drug increasing its stability against crystallization (the advantages of amorphous solids over their crystalline counterparts for many applications are well-known) [16, 17] .
We have also been able to dissolve the microcrystal while preserving the shell structure by simply submerging the microcapsules in water, demonstrating the shell porosity (see Figure 6c) . The process is irreversible, though, since no possible physicochemical mechanisms to raise again the salt concentration inside the capsule exist. This opens an unexpected universe of possibilities for medical and analytical applications (i.e., protein stability, controlled release, and controlled crystal growth for analysis by x-ray diffraction [18] or transmission electron microscopy observations [19] ).
Conclusions
In summary, PLGA microcapsules produced by flow focusing show nearly homogeneous size, well-centered core and their size and structure is well predicted by simple theoretical models.
This study represents a new milestone for the field of cells and drug microencapsulation and the start point to explore new applications. 4.2. Experimental Setup. Making use of a flow focusing device [3, 6] with an exit orifice diameter of 250 μm and a concentric feeding capillary setup as sketched in Figure 7 , we have made a detailed study where different gas pressures, and inner and outer liquid flow rates have been explored. Nozzle dimensions were as follows: D = 250 μm, H = 125 μm, di = 75/150 μm (inner/outer diameter inner capillary tube), de = 260/500 (500/260) (inner outer diameter outer capillary tube) μm, and dp = 100 μm (distance between the tips of both capillaries).
4.3. Liquids Characterization. Density, viscosity (Brookfield, mod. LVDVE 230), and tensile strength (KSV instruments, mod. CAM 101) were measured for each solution/suspension assayed. We have used a solution of PLGA in ethyl acetate (3% w/v, density ρ 2 = 910 kg·m −3 , viscosity μ 2 = 1.2 kg/m/s) to form the shell of the microcapsule.
To form the core, different diluted aqueous solutions (density ρ 1 =1005 kg·m −3 , viscosity μ 2 =1.05 Pa·s) have been used. The interfacial tension measured between water and the PLGA solution was σ 12 = 5.9 mN/m, while the one between the PLGA solution and air was σ 2 = 23.4 mN/m. 4.4. Microcapsules Production 4.4.1. Control of Shell-Core Ratio. Commercial blue ink was used as core, and PLGA, as shell materials. Pressure was fixed at 125 mbar, and a wide range of liquid rates were assayed in order to study their effects on shell and core dimensions (PLGA rates: 2, 3, 4, and 5 mL/h; ink rates: 0.25, 0.5, 0.75, and 1 mL/h).
4.4.2. Microorganisms Encapsulation. PLGA was assayed as biocompatible shell-forming agent when bacterial and yeast cells were encapsulated. As example, a 3% w/v solution of the PLGA in ethyl acetate (EA) was used as the shell-forming agent. Recombinant E. coli (10 5 cells/mL) or recombinant S. cerevisiae expressing green fluorescent protein (GFP) (10 5 yeast/mL) in PBS was then used as core material.
4.4.3. Protein and Crystals Encapsulation. In this case, PLGA was also used as shell material and a solution of green fluorescent protein (GFP) or sodium chloride in distilled water (1% w/v) was used as core material.
The evaporation process is run at T = 56°C in a heated air environment. Most of their solvent content (both the external ethyl acetate and the internal water) is then evaporated. The dried microcapsules formed are then collected and examined under the microscope.
4.4.3.1. Size, Morphology, and Structure of Microcapsules. Diameters from dried samples were determined by using an optical microscope and an image processing program (Image J, 1.30v). Diameters were measured for 100-500 microparticles from various micrograph images, and statistical data were calculated.
The shape and surface characteristics of microspheres were determined by optic and scanning electron microscopy (SEM) (Philips XL-30).
Microcapsules fluorescence properties were determined with confocal fluorescence microscopy (CLSM) (LEICA TCS-SP2, software Leica LAS AF).
